Proton magnetic resonance spectroscopy (1 H-MRS) in ALS

Amyotrophic Lateral Sclerosis

Volumn 1, Issue SUPPL. 2, 2000, Pages

  Pioro, Erik P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

1H MRS; diagnosis; neurological disorders; upper motor neuron dysfunction

Indexed keywords

PROTON;

AMYOTROPHIC LATERAL SCLEROSIS; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 0002353987     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820052415772     Document Type: Review

References (24)

1. Ross BD, Bluml S. Neurospectroscopy. In: Greenberg JO (ed). Neuroimaging. New York, NY: McGraw-Hill 1999: 727-774.
2. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994; 44: 1933-1938. (Pubitemid 24319224)
3. Jones AP, Gunawardena WJ, Coutinho CMA, Gatt JA, Shaw IC, Mitchell JD. Preliminary results of proton magnetic resonance spectroscopy in motor neuron disease (amyotrophic lateral sclerosis). J Neurol Sci 1995; 129: 85-89.
4. Cwik VA, Hanstock C, Allen PS, Martin WRW. Estimation of brainstem neuronal loss in ALS with in vivo proton MR spectroscopy. Neurology 1998; 50: 72-77.
5. Ellis CM, Simmons A, Andrews C, Dawson JM, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998; 51: 1104-1109. (Pubitemid 28473408)
6. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997; 48: 878-881.
7. Pioro EP. MR spectroscopy in amyotrophic lateral sclerosis/ motor neuron disease. J Neurol Sci 1997; 152: S49-S53. (Pubitemid 27505290)
8. Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC. 1HMRS evidence of neurodegeneration and excess glutamate1 glutamine in ALS medulla. Neurology 1999; 53: 71-79. (Pubitemid 29329651)
9. Block W, Karitzky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 1998; 55: 931-936. (Pubitemid 28335111)
10. Brand A, Engelmann J, Leibfritz D. A 13C NMR study on fluxes into the TCA cycle of neuronal and glial tumor cell lines and primary cells. Biochimie 1992; 74: 941-948.
11. Rothstein JD. Excitotoxicity hypothesis. Neurology 1996; 47: S19-S26. (Pubitemid 26361991)
12. Bradley WG, Bowen BC, Pattany PM, Rotta FT. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999; 169: 84-86. (Pubitemid 29502512)
13. Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of singlevoxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999; 212: 763-769. (Pubitemid 29410981)
14. Giroud M, Walker P, Bernard D, et al. Reduced brain Nacetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol Res 1996; 18: 241-243. (Pubitemid 26323664)
15. Mandler RN, Petropoulos H, Meister M, Werner J, Brooks WM. Magnetic spectroscopy surrogate markers in amyotrophic lateral sclerosis. Neurology 1999; 52: A1-A2.
16. Pioro EP. Imaging in amyotrophic lateral sclerosis. In: Brown RH, Jr, Meininger V, Swash M (eds). Amyotrophic Lateral Sclerosis. London: Martin Dunitz, Ltd., 2000: 187-208.
17. Pouget J, Trefouret S, Attarian S. Transcranial magnetic stimulationn. In: Brown RH, Jr, Meininger V, Swash M (eds). Amyotrophic Lateral Sclerosis. London: Martin Dunitz Ltd, 2000: 179-185.
18. Eisen AA. Corticospinal motor neurons: pathophysiology. In: Brown RH, Jr, Meininger V, Swash M (eds). Amyotrophic Lateral Sclerosis. London: Martin Dunitz Ltd, 2000: 161-177.
19. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998; 50: 1800-1805. (Pubitemid 28283255)
20. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of Nacetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. NeuroReport 1998; 9: 1757-1761. (Pubitemid 28289180)
21. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970; 33: 338-357.
22. Mitsumoto H, Chad DC, Pioro EP. Neuroimaging. In: Amyotrophic Lateral Sclerosis. Philadelphia, PA: Oxford University Press, 1998: 134-150.
23. Pioro EP, Wang Y, Moore JK, et al. Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry. NeuroReport 1998; 9: 3041-3046. (Pubitemid 28555643)
24. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679. (Pubitemid 23360802)